Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Gene Therapy in Tissue-Engineered Blood Vessels
Ryan C. Fields
, Amy Solan
, Kevin T. McDonagh
, Laura E. Niklason
, Jeffrey H. Lawson
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Division of General Surgery
Section of Surgical Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
19
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Gene Therapy in Tissue-Engineered Blood Vessels'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Gene Therapy
100%
Endothelial Cells
100%
Blood Vessels
100%
Tissue-engineered Blood Vessel
100%
Engineered Vessel
100%
United States
50%
Gene Delivery
50%
Cardiovascular Disease
50%
Specific Genes
50%
Prosthetic Grafts
50%
Gene Delivery System
50%
Tissue Engineering
50%
Peripheral Circulation
50%
Bypass Surgery
50%
Vascular Bed
50%
Bypass Procedure
50%
Therapeutic Gene
50%
Biological Graft
50%
Delivery Approaches
50%
Coronary Circulation
50%
Surgical Implantation
50%
Gene of Interest
50%
Arterial Bypass
50%
Western Societies
50%
Autologous Cells
50%
Vascular Graft
50%
Autologous Vein Graft
50%
Medicine and Dentistry
Gene Therapy
100%
Vascular Bundle
100%
Engineered Tissue
100%
Endothelial Cell
66%
Ex Vivo
33%
Cardiovascular Disease
33%
Coronary Circulation
33%
Gene Targeting
33%
Peripheral Circulation
33%
Bypass Surgery
33%
Tissue Regeneration
33%
Blood Vessel Graft
33%
Artery Bypass
33%
Gene Delivery
33%
Immunology and Microbiology
Blood Vessels
100%
Engineered Tissue
100%
Gene Targeting
33%
Artery
33%
Vein
33%
Artery Bypass
33%
Peripheral Circulation
33%
Tissue Regeneration
33%
Gene Delivery System
33%
Pharmacology, Toxicology and Pharmaceutical Science
Gene Delivery
100%
Gene Delivery
100%
Cardiovascular Disease
100%
Biochemistry, Genetics and Molecular Biology
Gene Therapy
100%
Gene Targeting
50%
Peripheral Circulation
50%
Tissue Regeneration
50%
Gene Delivery
50%